PhRMA

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from PhRMA, Medical and health, 670 Maine Avenue SW Ste. 1000, Washington D.C., DC.

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments.

02/14/2026

Seeing double? It’s not just you.

Each of the big three PBMs, which manage nearly 80% of prescriptions in the U.S., are now part of the same companies as the three largest health insurers - creating mega health care situationships. This means they’re steering patients to pharmacies they own at your expense.

These middlemen are driving up costs through consolidation or even ghosting your access. 🚩 Patients deserve better.

https://phrma.org/policy-issues/pbms-middlemen

02/13/2026

Takeda is committed to maintaining America’s leadership in biopharmaceutical innovation, investing $30 billion in U.S. manufacturing and R&D through the end of the decade.

Employing cutting-edge tech and empowering the next generation of innovators, Takeda is fueling a vibrant life sciences ecosystem in Massachusetts and making a real difference for America’s patients.

Learn more about Takeda’s success story:

https://innovation.org/casestudy/takeda-powers-us-biopharma-leadership-and-innovation/

02/11/2026

In her opening testimony before the House Energy & Commerce Health Subcommittee, PhRMA COO Lori Reilly highlighted three important points.

02/10/2026

Marking a major milestone in their $23 billion U.S. expansion plan, Novartis US has opened their new 10,000-square-foot Radioligand Therapy (RLT) manufacturing facility in Carlsbad, CA.

This site strengthens American leadership in RLT innovation, delivers pioneering treatment to patients and brings engineering and manufacturing jobs to the region.
Hear more about this development from Novartis:

https://innovation.org/casestudy/novartis-strengthens-american-manufacturing-leadership/

02/05/2026

America is the only country in the world where half of every dollar spent on brand medicines goes to middlemen and others that don’t make them.

In fact, patients are paying more than they should and facing barriers to care because middlemen are using medicines as a profit center.

It is time to put America’s patients first. That starts with holding middlemen accountable.

https://www.phrma.org/policy-issues/pbms-middlemen

02/04/2026

“We are committed to lowering costs and tackling patient affordability challenges with the same innovative spirit that we apply to our own scientific research.”

Genentech CEO Ashley Magargee sat down for a fireside chat with PhRMA’s Scott LaGanga to discuss Genentech’s work fostering an innovation-friendly policy environment while ensuring that American patients can afford the medicines they need.

Watch the full conversation here:
https://youtu.be/SFdn-YnHaKo?si=V40e8T3Oefu72iNx

02/03/2026

BREAKING: PBM reform has just been signed into law.

This marks a major step toward holding middlemen accountable and bringing down patient costs.

Now, policymakers should explore additional reforms to address the harmful consequences of growing consolidation among PBMs and insurers who are increasingly denying care to patients.

02/02/2026

Thanks to IP, medicine is the only part of our health care system that gets cheaper over time. Our intellectual property protections work to balance innovation and affordability, providing U.S. patients with more medicine choices than anywhere else in the world. With over 8,000 innovative medicines in development, this system continues to fuel groundbreaking treatment advances.

Learn more about the importance of our world-class innovation ecosystem:
https://phrma.org/policy-issues/intellectual-property

01/30/2026

The toll of measles is significant – research shows that just one 1,500-case measles outbreak would cost about $90 million in a single year.

This disease–and the cost and devastation associated with it–is entirely preventable.

There is overwhelming evidence that the MMR vaccine is safe and effective, and maintaining high vaccination rates is vital to curb its spread and protect the health of all Americans.

https://phrma.org/blog/what-you-need-to-know-measles-and-the-mmr-vaccine

01/29/2026

Founded 50 years ago, Genentech has been committed to changing patients’ lives for decades. Now, with 14 manufacturing sites and 15 research and development centers across the country, Genentech is a shining example of America’s continued biopharmaceutical leadership, developing and producing breakthrough medicines while employing thousands.

CEO Ashley Magargee explains how Genentech’s investment in North Carolina, where the company announced an additional investment just last week, expands on its legacy of job creation and innovation:

https://innovation.org/

01/27/2026

Under the 340B hospital markup program, tax-exempt hospitals can buy medicines at steep discounts and then mark them up by 1000% or more.

Enough is enough. America’s patients deserve better.

01/22/2026

Middlemen exercise significant control over:

👉What medicines you can get
👉What you pay at the pharmacy counter
👉What pharmacy you can use
👉What hoops you jump through to get the medicine your doctor prescribed

America’s patients deserve better. Washington must hold PBMs and insurers accountable.

https://phrma.org/blog/can-t-get-your-medicine-don-t-count-on-your-insurer

Address

670 Maine Avenue SW Ste. 1000
Washington D.C., DC
20024

Telephone

+12028353400

Website

https://www.PhRMA.org/

Alerts

Be the first to know and let us send you an email when PhRMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PhRMA:

Shortcuts

Want your practice to be the top-listed Clinic in Washington D.C.?